Amrize Ltd $AMRZ Stock Position Raised by Royal Bank of Canada

Royal Bank of Canada increased its holdings in shares of Amrize Ltd (NYSE:AMRZ) by 18.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 442,726 shares of the company’s stock after buying an additional 68,787 shares during the period. Royal Bank of Canada’s holdings in Amrize were worth $24,801,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. MCF Advisors LLC bought a new position in shares of Amrize during the fourth quarter valued at approximately $27,000. Basepoint Wealth LLC bought a new stake in shares of Amrize in the 4th quarter worth approximately $33,000. Laurel Wealth Advisors LLC acquired a new position in Amrize during the 4th quarter valued at approximately $34,000. US Bancorp DE acquired a new position in Amrize during the 3rd quarter valued at approximately $38,000. Finally, Itau Unibanco Holding S.A. boosted its position in Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after purchasing an additional 450 shares during the period.

Amrize Stock Up 1.4%

NYSE AMRZ opened at $51.82 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The company’s 50 day simple moving average is $52.13 and its 200 day simple moving average is $54.81. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $65.94. The company has a market capitalization of $28.66 billion, a P/E ratio of 24.79, a PEG ratio of 1.08 and a beta of 0.11.

Amrize Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is 21.05%.

Insider Buying and Selling at Amrize

In related news, insider Mario Gross purchased 2,800 shares of the company’s stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $49.17 per share, with a total value of $137,676.00. Following the completion of the acquisition, the insider owned 33,747 shares of the company’s stock, valued at approximately $1,659,339.99. This represents a 9.05% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CTO Roald Brouwer acquired 1,500 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were bought at an average price of $49.84 per share, with a total value of $74,760.00. Following the transaction, the chief technology officer directly owned 19,757 shares in the company, valued at approximately $984,688.88. The trade was a 8.22% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have bought 54,918 shares of company stock worth $2,717,324. 0.54% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

AMRZ has been the topic of several analyst reports. Stephens reaffirmed an “overweight” rating and issued a $65.00 target price on shares of Amrize in a research report on Monday, May 18th. Wells Fargo & Company lowered their price target on shares of Amrize from $65.00 to $58.00 and set an “overweight” rating for the company in a research report on Wednesday, July 8th. Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Friday, May 1st. Oppenheimer reduced their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating for the company in a research note on Tuesday, July 21st. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a research report on Friday, June 26th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Amrize currently has a consensus rating of “Moderate Buy” and a consensus target price of $62.79.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.